Quitterie Fontanges

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Integrated Clinicopathological and Multiomic Profiling Reveals MEIS1-rearranged Sarcoma as a Distinct Entity with Two Prognostic Subgroups.

Integrated Clinicopathological and Multiomic Profiling Reveals MEIS1-rearranged Sarcoma as a Distinct Entity with Two Prognostic Subgroups.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: May 04, 2026

Uterine sarcoma with KAT6B/A::KANSL1 fusion: an evolving entity.

Uterine sarcoma with KAT6B/A::KANSL1 fusion: an evolving entity.

Journal: Virchows Archiv : an international journal of pathology

Published: December 13, 2024

Challenges of a tailored immunohistochemistry algorithm for uterine leiomyosarcoma: an integrated analysis of leiomyomas with bizarre nuclei and fumarate hydratase (FH) deficiency.

Challenges of a tailored immunohistochemistry algorithm for uterine leiomyosarcoma: an integrated analysis of leiomyomas with bizarre nuclei and fumarate hydratase (FH) deficiency.

Journal: Histopathology

Published: November 04, 2024

Evaluation of trophoblast cell surface antigen-2 (TROP2) protein expression in chemotherapy-resistant and metastatic breast carcinomas.

Evaluation of trophoblast cell surface antigen-2 (TROP2) protein expression in chemotherapy-resistant and metastatic breast carcinomas.

Journal: Pathology, research and practice

Published: September 28, 2024

Translocation-associated uterine mesenchymal tumors: The new without forgetting the old. An integrated diagnostic approach

Translocation-associated uterine mesenchymal tumors: The new without forgetting the old. An integrated diagnostic approach

Journal: Annales de pathologie

Published: April 10, 2024

Genomic profile analysis of leiomyomas with bizarre nuclei and fumarate hydratase deficient leiomyomas: Strengths, weaknesses, and limitations of array-CGH interpretation.

Genomic profile analysis of leiomyomas with bizarre nuclei and fumarate hydratase deficient leiomyomas: Strengths, weaknesses, and limitations of array-CGH interpretation.

Journal: Genes, chromosomes & cancer

Published: June 05, 2023

Endometrial biopsy and curettage histoseminar. Case No. 6

Endometrial biopsy and curettage histoseminar. Case No. 6

Journal: Annales de pathologie

Published: February 11, 2021

Endometrial biopsy and curettage histoseminar. Case no 5

Endometrial biopsy and curettage histoseminar. Case no 5

Journal: Annales de pathologie

Published: February 11, 2021

"Bacteria in pack" contamination

"Bacteria in pack" contamination

Journal: Annales de pathologie

Published: September 20, 2019

The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine Leiomyosarcomas.

The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine Leiomyosarcomas.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 03, 2019

Esophagitis dissecans superficialis : a case series of 7 patients and review of the literature.

Esophagitis dissecans superficialis : a case series of 7 patients and review of the literature.

Journal: Acta gastro-enterologica Belgica

Published: March 22, 2018

Clinical application of targeted next-generation sequencing for colorectal cancer patients: a multicentric Belgian experience.

Clinical application of targeted next-generation sequencing for colorectal cancer patients: a multicentric Belgian experience.

Journal: Oncotarget

Published: December 12, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026